-
UK public urged to keep eyes peeled for washed-up bananas
-
South Korea chip giant SK hynix mulls US stock market listing
-
Captain Cummins back in Australia squad for third Ashes Test
-
NFL Colts to bring 44-year-old QB Rivers out of retirement: reports
-
West Indies 92-2 after being asked to bat in second New Zealand Test
-
Ruckus in Brazil Congress over bid to reduce Bolsonaro jail term
-
ExxonMobil slows low-carbon investment push through 2030
-
Liverpool's Slot swerves further Salah talk after late Inter win
-
Maresca concerned as Atalanta fight back to beat Chelsea
-
Liverpool edge Inter in Champions League as Chelsea lose in Italy
-
Spurs sink Slavia Prague to boost last-16 bid in front of Son
-
Arsenal ensure Women's Champions League play-off berth
-
Canada launches billion dollar plan to recruit top researchers
-
Liverpool defy Salah crisis by beating Inter Milan in Champions League
-
Honduran leader alleges vote tampering, US interference
-
De Ketelaere inspires Atalanta fightback to beat Chelsea
-
Kounde double helps Barcelona claim Frankfurt comeback win
-
US Supreme Court weighs campaign finance case
-
Zelensky says ready to hold Ukraine elections, with US help
-
Autistic Scottish artist Nnena Kalu smashes Turner Prize 'glass ceiling'
-
Trump slams 'decaying' and 'weak' Europe
-
Injury-hit Arsenal in 'dangerous circle' but Arteta defends training methods
-
Karl and Gnabry spark Bayern to comeback win over Sporting
-
Thousands flee DR Congo fighting as M23 closes on key city
-
Indigenous artifacts returned by Vatican unveiled in Canada
-
Ivory Coast recall Zaha for AFCON title defence
-
Communist vs Catholic - Chile prepares to choose a new president
-
Trump's FIFA peace prize breached neutrality, claims rights group
-
NHL 'optimistic' about Olympic rink but could pull out
-
Thousands reported to have fled DR Congo fighting as M23 closes on key city
-
Three face German court on Russia spying charges
-
Amy Winehouse's father sues star's friends for auctioning her clothes
-
Woltemade's 'British humour' helped him fit in at Newcastle - Howe
-
UK trial opens in dispute over Jimi Hendrix recordings
-
Pandya blitz helps India thrash South Africa in T20 opener
-
Zelensky says will send US revised plan to end Ukraine war
-
Miami's Messi wins second consecutive MLS MVP award
-
Trump slams 'decaying' Europe and pushes Ukraine on elections
-
TotalEnergies in deal for Namibia offshore oil field
-
Jesus added to Arsenal's Champions League squad
-
Red Bull part ways with influential advisor Marko
-
India's biggest airline IndiGo says operations 'back to normal'
-
Venezuela's 'joropo' dance declared a UNESCO treasure
-
Salah trains in Liverpool as Saudis plan winter transfer move
-
Police raid Argentine football HQ, clubs in graft probe
-
Ukraine should hold elections, Trump says
-
Anguished Sri Lankans queue for care after deadly cyclone
-
Save the Elephants founder Iain Douglas-Hamilton dies at 83
-
Why west African troops overturned Benin's coup but watched others pass by
-
Microsoft announces $17.5 bn investment in India, its 'largest ever' in Asia
What is microRNA? Nobel-winning discovery explained
The Nobel Prize in Medicine was awarded on Monday to two US scientists for discovering microRNA, a previously unknown type of genetic switch which is hoped can pave the way for new medical breakthroughs.
But while several treatments and tests are under development using microRNAs against cancer, heart disease, viruses and other illnesses, none have actually yet reached patients.
And the world paid little attention when the new Nobel laureates Victor Ambros and Gary Ruvkun revealed their discovery decades ago, thinking it was just "something weird about worms", Cambridge University geneticist Eric Miska told AFP.
Here is an explainer about how exactly these tiny genetic switches work inside our bodies.
- What is microRNA? -
Each cell in the human body has the same set of instructions, called DNA. Some turn into brain cells, while others become muscles.
So how do the cells know what to become? The relevant part of the DNA's instructions is pointed to via a process called gene regulation.
Ribonucleic acid (RNA) normally serves as a messenger. It delivers the instructions from the DNA to proteins, which are the building blocks of life that turn cells into brains -- or muscles.
Miska gave the example of the messenger RNA vaccines rolled out against Covid-19 during the pandemic, which insert a message with new instructions to build proteins that block viruses.
But the two new Nobel winners Ambros and Ruvkun discovered a whole new type of gene regulator that had previously been overlooked by science.
Rather than being the messenger which relays information, microRNA instead acts as a switch to turn other genes off and on.
"This was a whole new level of control that we had totally missed," said Miska, who has worked on microRNA for two decades, including with the new Nobel laureates.
"The discovery of microRNAs brought an additional level of complexity by revealing that regions that were thought to be non-coding play a role in gene regulation," French researcher Benoit Ballester told AFP.
- What did the Nobel winners do? -
Back in the 1980s, Ambros and Ruvkun had been working separately on how genes interact in one-millimetre-long roundworms called C.elegans.
When they compared their work, it led to the discovery of microRNA. Ambros revealed the finding in a 1993 paper.
"Nobody really paid much attention," Miska said, explaining that most scientists at the time thought it only applied to worms.
Then in 2000, Ruvkun published research showing that microRNA is present right across the animal kingdom, including in humans and even some viruses.
"This was not just something weird that worms do, but in fact all animals and plants are totally dependent for development and normal function on them," Miska said.
More than a thousand genes that respond to microRNAs are now believed to be in the human body.
- How could this help us? -
There are numerous new treatments and tests using microRNA that are undergoing trials but none have been made widely available.
"Though there are no very clear applications available yet in microRNAs, understanding them, knowing that they exist, understanding their counter-regulatory networks, is always the first step," the Karolinska Institute's Gunilla Karlsson Hedestam told journalists in Stockholm.
MicroRNAs are particularly promising for fighting cancer because some of these switches "act as a tumour suppressor, so they put a brake on cells dividing inappropriately," Miska said.
Others, meanwhile, induce "cells to divide, which can lead to cancer", he added.
Because many viruses use microRNAs, several antiviral drugs are at varying stages of development, including for hepatitis C.
One complicating factor has been that microRNAs can be unstable.
But scientists also hope they can be used as a test called a "biomarker", which could reveal what type of cancer a patient could be suffering from, for example.
- What next? -
It also appears probable that microRNAs could be involved in the evolution of our species, Miska said.
While human brains are difficult to study, Miska hoped future research will discover more.
G.Machado--PC